ONCOLOGY_HEADER

MEDICAMEN BIOTECH LIMITED IS NOW NSE LISTED

WE ARE NOW NSE LISTED!

Medicamen Biotech Limited is now NSE LISTED

ONCOLOGY_HEADER

Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.

Poised to launch novel oncology products

Company is poised to launch novel oncology products in the FY 2021- 2022 in Indian region and South East Asian markets.

ONCOLOGY_HEADER

Haridwar Unit 1 for formulations is WHO GMP approved

WHO GMP approved

Haridwar Unit 1 for formulations is WHO GMP approved

ONCOLOGY_HEADER

ANDA filing for oncology formulations in process

Abbreviated New Drug Application (ANDA) filing process

ANDA filing for oncology formulations in process

24

Sed ut perspiciatis

Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur

MBl-_LOGO1A

Infrastructure & Research

API Facility

Corporate R&D

Contact Info

Address Details

1506, Chiranjiv Tower, 43 Nehru Place, New Delhi - 110019 (India)

+91-11-47589500,
info@medicamen.com

Daily: 9:00 am - 6:00 pm
Sunday: Closed

Copyright 2018 MEDICAMEN BIOTECH LIMITED ©  All Rights Reserved